FY2026 EPS Estimates for Liquidia Decreased by HC Wainwright

Liquidia Corporation (NASDAQ:LQDA) – Stock analysts at HC Wainwright cut their FY2026 earnings per share estimates for Liquidia in a research report issued to clients and investors on Thursday, August 13th. HC Wainwright analyst A. Fein now anticipates that the company will earn $3.44 per share for the year, down from their previous estimate of $3.97. The consensus estimate for Liquidia’s current full-year earnings is $2.57 per share. HC Wainwright also issued estimates for Liquidia’s Q4 2026 earnings at $1.18 EPS, FY2027 earnings at $6.41 EPS, FY2028 earnings at $7.39 EPS, FY2029 earnings at $9.01 EPS and FY2030 earnings at $10.08 EPS.

Several other equities research analysts have also commented on the stock. Zacks Research lowered shares of Liquidia from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 13th. Wall Street Zen downgraded Liquidia from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 27th. Bank of America upped their target price on Liquidia from $79.00 to $92.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. Lifesci Capital lowered Liquidia from an “outperform” rating to a “hold” rating and set a $90.00 target price for the company. in a report on Wednesday, August 12th. Finally, Oppenheimer set a $75.00 price target on Liquidia in a research report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Liquidia presently has an average rating of “Hold” and an average target price of $98.08.

Liquidia Stock Down 4.3%

Liquidia stock opened at $74.33 on Monday. Liquidia has a fifty-two week low of $21.15 and a fifty-two week high of $93.61. The stock has a market cap of $6.65 billion, a PE ratio of 54.26 and a beta of 0.58. The firm’s 50-day simple moving average is $79.15 and its 200 day simple moving average is $55.70. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.12 and a current ratio of 2.31.

Liquidia (NASDAQ:LQDA) last posted its earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a return on equity of 149.65% and a net margin of 30.74%.The firm had revenue of $171.68 million during the quarter, compared to the consensus estimate of $168.48 million. During the same quarter in the previous year, the company earned ($0.49) EPS. The business’s revenue was up 1842.1% compared to the same quarter last year.

Insider Activity

In related news, Director Paul B. Manning sold 200,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $63.91, for a total transaction of $12,782,000.00. Following the completion of the sale, the director owned 716,311 shares in the company, valued at approximately $45,779,436.01. This trade represents a 21.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Stephen M. Bloch sold 242,269 shares of Liquidia stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $70.43, for a total transaction of $17,063,005.67. Following the completion of the sale, the director directly owned 1,176,184 shares in the company, valued at approximately $82,838,639.12. This represents a 17.08% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 1,731,861 shares of company stock valued at $121,514,862. 25.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Liquidia

Hedge funds have recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. bought a new position in Liquidia during the fourth quarter valued at $25,000. NewEdge Advisors LLC purchased a new stake in Liquidia in the second quarter worth $25,000. Covestor Ltd raised its stake in shares of Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after buying an additional 359 shares during the period. Tower Research Capital LLC TRC raised its stake in shares of Liquidia by 281.2% in the second quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company’s stock valued at $83,000 after buying an additional 4,927 shares during the period. Finally, Globeflex Capital L P bought a new stake in shares of Liquidia in the second quarter valued at $175,000. Institutional investors own 64.54% of the company’s stock.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).